GLAXO
Invest with MTF
Invest Now
Invest in GlaxoSmithKline Pharmaceuticals with 3.23X leverage
Performance
- Low
- ₹2,585
- High
- ₹2,639
- 52 Week Low
- ₹2,087
- 52 Week High
- ₹3,516
- Open Price₹2,590
- Previous Close₹2,594
- Volume34,053
- 50 DMA₹2,491.97
- 100 DMA₹2,558.43
- 200 DMA₹2,627.28
Investment Returns
- Over 1 Month + 8.46%
- Over 3 Month + 4.76%
- Over 6 Month -6.22%
- Over 1 Year + 28.71%
Smart Investing Starts Here Start SIP with GlaxoSmithKline Pharmaceuticals for Steady Growth!
GlaxoSmithKline Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 43.1
- PEG Ratio
- 2.3
- Market Cap Cr
- 44,000
- P/B Ratio
- 25.8
- Average True Range
- 79.68
- EPS
- 59.37
- Dividend Yield
- 1.6
- MACD Signal
- 25.74
- RSI
- 59.93
- MFI
- 66.05
GlaxoSmithKline Pharmaceuticals Financials
GlaxoSmithKline Pharmaceuticals Technicals
EMA & SMA
Current Price
₹2,597.30
+
2.9
(0.11%)
- Bearish Moving Average 5
- Bullish Moving Average 11
- 20 Day
- ₹2,504.44
- 50 Day
- ₹2,491.97
- 100 Day
- ₹2,558.43
- 200 Day
- ₹2,627.28
Resistance and Support
2607.03
- R3 2,683.47
- R2 2,661.23
- R1 2,629.27
- S1 2,575.07
- S2 2,552.83
- S3 2,520.87
GlaxoSmithKline Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
GlaxoSmithKline Pharmaceuticals F&O
About GlaxoSmithKline Pharmaceuticals
- NSE Symbol
- GLAXO
- BSE Symbol
- 500660
- Managing Director
- Mr. B Akshikar
- ISIN
- INE159A01016
Similar Stocks to GlaxoSmithKline Pharmaceuticals
GlaxoSmithKline Pharmaceuticals FAQs
GlaxoSmithKline Pharmaceuticals share price is ₹2,597 As on 17 February, 2026 | 01:04
The Market Cap of GlaxoSmithKline Pharmaceuticals is ₹43999.8 Cr As on 17 February, 2026 | 01:04
The P/E ratio of GlaxoSmithKline Pharmaceuticals is 43.1 As on 17 February, 2026 | 01:04
The PB ratio of GlaxoSmithKline Pharmaceuticals is 25.8 As on 17 February, 2026 | 01:04
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.